ES12077/ES/NIEHS NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2003	2
2004	1
2005	6
2006	7
2007	6
2008	2
2009	1
2010	2
2011	2
2024	0

1

The environment and Parkinson's disease: is the nigrostriatal system preferentially targeted by neurotoxins?

Di Monte DA. Di Monte DA. Lancet Neurol. 2003 Sep;2(9):531-8. doi: 10.1016/s1474-4422(03)00501-5. Lancet Neurol. 2003. PMID: 12941575 Review.

2

Striatal alpha6* nicotinic acetylcholine receptors: potential targets for Parkinson's disease therapy.

Quik M, McIntosh JM. Quik M, et al. J Pharmacol Exp Ther. 2006 Feb;316(2):481-9. doi: 10.1124/jpet.105.094375. Epub 2005 Oct 6. J Pharmacol Exp Ther. 2006. PMID: 16210393 Review.

3

Iron-enhanced paraquat-mediated dopaminergic cell death due to increased oxidative stress as a consequence of microglial activation.

Peng J, Stevenson FF, Oo ML, Andersen JK. Peng J, et al. Free Radic Biol Med. 2009 Jan 15;46(2):312-20. doi: 10.1016/j.freeradbiomed.2008.10.045. Epub 2008 Nov 7. Free Radic Biol Med. 2009. PMID: 19027846 Free PMC article.

4

Lysosomal degradation of alpha-synuclein in vivo.

Mak SK, McCormack AL, Manning-Bog AB, Cuervo AM, Di Monte DA. Mak SK, et al. J Biol Chem. 2010 Apr 30;285(18):13621-9. doi: 10.1074/jbc.M109.074617. Epub 2010 Mar 3. J Biol Chem. 2010. PMID: 20200163 Free PMC article.

5

Redox cycling of the herbicide paraquat in microglial cultures.

Bonneh-Barkay D, Reaney SH, Langston WJ, Di Monte DA. Bonneh-Barkay D, et al. Brain Res Mol Brain Res. 2005 Mar 24;134(1):52-6. doi: 10.1016/j.molbrainres.2004.11.005. Epub 2005 Jan 6. Brain Res Mol Brain Res. 2005. PMID: 15790529

6

Pathologic modifications of alpha-synuclein in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated squirrel monkeys.

McCormack AL, Mak SK, Shenasa M, Langston WJ, Forno LS, Di Monte DA. McCormack AL, et al. J Neuropathol Exp Neurol. 2008 Aug;67(8):793-802. doi: 10.1097/NEN.0b013e318180f0bd. J Neuropathol Exp Neurol. 2008. PMID: 18648323 Free PMC article.

7

Coffee, ADORA2A, and CYP1A2: the caffeine connection in Parkinson's disease.

Popat RA, Van Den Eeden SK, Tanner CM, Kamel F, Umbach DM, Marder K, Mayeux R, Ritz B, Ross GW, Petrovitch H, Topol B, McGuire V, Costello S, Manthripragada AD, Southwick A, Myers RM, Nelson LM. Popat RA, et al. Eur J Neurol. 2011 May;18(5):756-65. doi: 10.1111/j.1468-1331.2011.03353.x. Epub 2011 Jan 31. Eur J Neurol. 2011. PMID: 21281405 Free PMC article.

8

Comparison of the neurotoxic effects of proteasomal inhibitors in primary mesencephalic cultures.

Reaney SH, Johnston LC, Langston WJ, Di Monte DA. Reaney SH, et al. Exp Neurol. 2006 Dec;202(2):434-40. doi: 10.1016/j.expneurol.2006.07.010. Epub 2006 Aug 22. Exp Neurol. 2006. PMID: 16920101

9

Alpha-synuclein expression in the substantia nigra of MPTP-lesioned non-human primates.

Purisai MG, McCormack AL, Langston WJ, Johnston LC, Di Monte DA. Purisai MG, et al. Neurobiol Dis. 2005 Dec;20(3):898-906. doi: 10.1016/j.nbd.2005.05.028. Epub 2005 Jul 11. Neurobiol Dis. 2005. PMID: 16006134

10

Synergistic effects of environmental risk factors and gene mutations in Parkinson's disease accelerate age-related neurodegeneration.

Peng J, Oo ML, Andersen JK. Peng J, et al. J Neurochem. 2010 Dec;115(6):1363-73. doi: 10.1111/j.1471-4159.2010.07036.x. Epub 2010 Nov 4. J Neurochem. 2010. PMID: 21039522 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25 results

Results by year